Targeted binding of PEG-lipid modified polymer ultrasound contrast agents with tiered surface architecture

Biotechnology and Bioengineering

Volumn 106, Issue 3, 2010, Pages 501-506

  Duncanson, Wynter J ^a   Oum, Kelleny ^b   Eisenbrey, John R ^b   Cleveland, Robin O ^a   Wheatley, Margaret A ^b   Wong, Joyce Y ^a  

^a Boston University   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

Binding; In vitro; PEG lipid; Polymer; Ultrasound contrast agent

Indexed keywords

ARGININE-GLYCINE-ASPARTIC ACIDS; B-MODE IMAGES; BINDING; BIOTIN-AVIDIN LINKAGE; DISEASED TISSUES; DOUBLE EMULSIONS; FUNCTIONALIZED; GRAFTED POLYMERS; IN VITRO; INSONATION; MODIFIED POLYMER; NORMAL TISSUE; OIL PHASE; SHEAR CONDITIONS; SOLVENT EVAPORATION; SURFACE ARCHITECTURES; ULTRASOUND CONTRAST AGENT;

AMINO ACIDS; EMULSIFICATION; LIPIDS; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYMERS; ULTRASONICS;

FUNCTIONAL POLYMERS;

ARGINYLGLYCYLASPARTIC ACID; AVIDIN; BIOTIN; ECHO CONTRAST MEDIUM; LIPID; MACROGOL; POLYMER; SOLVENT;

ARTICLE; BINDING AFFINITY; BRIGHTNESS; ECHOGRAPHY; IMAGE QUALITY; SHEAR FLOW; SURFACE PROPERTY;

ANIMALS; CONTRAST MEDIA; LIPID METABOLISM; POLYETHYLENE GLYCOLS; POLYMERS; ULTRASONOGRAPHY;

EID: 77953548564     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22678     Document Type: Article

References (33)

1. Albertsson A-C. 2002. Degradable aliphatic polyesters. Berlin, London: Springer, p 179, viii.
2. Alon R, Bayer EA, Wilchek M. 1990. Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin. Biochem Biophys Res Commun 170(3):1236-1241.
3. Arshady R. 1990. Microspheres and microcapsules, a survey of manufacturing techniques: Part III: Solvent evaporation. Polym Eng Sci 30(15):915-924. (Pubitemid 20731553)
4. Bedu-Addo FK, Tang P, Xu Y, Huang L. 1996. Interaction of polyethyleneglycol-phospholipid conjugates with cholesterol-phosphatidylcholine mixtures: Sterically stabilized liposome formulations. Pharm Res 13(5):718-724.
5. Bloch SH, Dayton PA, Ferrara KW. 2004. Targeted imaging using ultrasound contrast agents. Progess and opportunities for clinical and research applications. IEEE Eng Med Biol Mag 23(5):18-29.
6. Borden MA, Zhang H, Gillies RJ, Dayton PA, Ferrara KW. 2008. A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials 29(5):597-606. (Pubitemid 350100802)
7. Chen CC, Dormidontova EE. 2005. Architectural and structural optimization of the protective polymer layer for enhanced targeting. Langmuir 21(12):5605-5615.
8. Chen WS, Matula TJ, Brayman AA, Crum LA. 2003. A comparison of the fragmentation thresholds and inertial cavitation doses of different ultrasound contrast agents. J Acoust Soc Am 113(1):643-651.
9. Cui W, Bei J, Wang S, Zhi G, Zhao Y, Zhou X, Zhang H, Xu Y. 2005. Preparation and evaluation of poly(L-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography. J Biomed Mater Res B Appl Biomater 73(1):171-178.
10. Diaz-Lopez R, Tsapis N, Libong D, Chaminade P, Connan C, Chehimi MM, Berti R, Taulier N, Urbach W, Nicolas V, Fattal E, 2009. Phospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents. Biomaterials 30(8):1462-1472.
11. Duncanson WJ, Figa MA, Hallock K, Zalipsky S, Hamilton JA, Wong JY. 2007. Targeted binding of PLA microparticles with lipid-PEG-tethered ligands. Biomaterials 28(33):4991-4999. (Pubitemid 47362347)
12. El-Sherif DM, Wheatley MA. 2003. Development of a novel method for synthesis of a polymeric ultrasound contrast agent. J Biomed Mater Res 66(2):347-355.
13. Fahmy TM, Samstein RM, Harness CC, Mark Saltzman W. 2005. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials 26(28):5727-5736.
14. Ferrara K, Pollard R, Borden M. 2007. Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 9:415-447. (Pubitemid 350246663)
15. Gref R, Domb A, Quellec P, Blunk T, Muller RH, Verbavatz JM, Langer R. 1995. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 16(2-3):215-233.
16. Gref R, Miralles G, Dellacherie E. 1999. Polyoxyethylene-coated nanospheres: Effect of coating on zeta potential and phagocytosis. Polym Int 48:251-256.
17. Gref R, Couvreur P, Barratt G, Mysiakine E. 2003. Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials 24(24):4529-4537. (Pubitemid 36960147)
18. Ham AS, Klibanov AL, Lawrence MB. 2009. Action at a distance: Lengthening adhesion bonds with poly(ethylene glycol) spacers enhances mechanically stressed affinity for improved vascular targeting of microparticles. Langmuir 25(17):10038-10044.
19. Hughes MS, Lanza GM, Marsh JN, Wickline SA. 2003. Targeted ultrasonic contrast agents for molecular imaging and therapy: A brief review. Medicamundi 47(1):66-73.
20. Klibanov AL. 2005. Ligand-carrying gas-filled microbubbles: Ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem 16(1):9-17. (Pubitemid 40129671)
21. Lathia JD, Leodore L, Wheatley MA. 2004. Polymeric contrast agent with targeting potential. Ultrasonics 42(1-9):763-768.
22. Longo G, Szleifer I. 2005. Ligand-receptor interactions in tethered polymer layers. Langmuir 21(24):11342-11351. (Pubitemid 41775100)
23. McCulloch M, Gresser C, Moos S, Odabashian J, Jasper S, Bednarz J, Burgess P, Carney D, Moore V, Sisk E, et al. 2000. Ultrasound contrast physics: A series on contrast echocardiography, article 3. J Am Soc Echocardiogr 13(10):959-967.
24. Narayan P, Wheatley MA. 1999. Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents. Polym Eng Sci 39(11):2242-2255. (Pubitemid 30528034)
25. Nighoghossian N, Derex L, Douek P. 2005. The vulnerable carotid artery plaque: Current imaging methods and new perspectives. Stroke 36(12):2764-2772.
26. Ophir J, Parker KJ. 1989. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 15(4):319-333.
27. Ottoboni S, Short RE, Kerby MB, Tickner EG, Steadman E, Ottoboni TB. 2006. Characterization of the in vitro adherence behavior of ultrasound responsive double-shelled microspheres targeted to cellular adhesion molecules. Contrast Media Mol Imaging 1(6):279-290.
28. Oum K. 2004. Polymeric ultrasound contrast agents targeted to malignancies: Optimization of contrast agent composition and cellular attachment. Master's Thesis, Drexel University, Philadelphia.
29. Pisani E, Tsapis N, Galaz B, Santin M, Berti R, Taulier N, Kurtisovski E, Lucidarme O, Ourevitch M, Doan BT, et al. 2008. Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging. Adv Funct Mater 18(19):2963-2971.
30. Raisinghani A, DeMaria AN. 2002. Physical principles of microbubble ultrasound contrast agents. Am J Cardiol 90(10A):3J-7J.
31. Takalkar AM, Klibanov AL, Rychak JJ, Lindner JR, Ley K. 2004. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release 96(3):473-482.
32. Wheatley MA, Lathia JD, Oum KL. 2007. Polymeric ultrasound contrast agents targeted to integrins: Importance of process methods and surface density of ligands. Biomacromolecules 8(2):516-522.
33. Wu SP, Ringgaard S, Oyre S, Hansen MS, Rasmus S, Pedersen EM. 2004. Wall shear rates differ between the normal carotid, femoral, and brachial arteries: An in vivo MRI study. J Magn Reson Imaging 19(2):188-193. (Pubitemid 38166795)